ClinVar Miner

Submissions for variant NM_022124.6(CDH23):c.9629_9632del (p.Ile3210fs)

dbSNP: rs397517367
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000039314 SCV000062998 pathogenic Rare genetic deafness 2012-05-08 criteria provided, single submitter clinical testing The Ile3210Argfs variant in CDH23 has not been reported in the literature. The v ariant is predicted to alter the protein?s amino acid sequence beginning at posi tion 3210 and lead to a premature termination codon 5 amino acids downstream. Th is alteration is then predicted to lead to a truncated or absent protein. In sum mary, this variant meets our criteria to be classified as pathogenic.
GeneDx RCV001009201 SCV001169020 pathogenic not provided 2019-02-25 criteria provided, single submitter clinical testing The c.9629_9632delTCAA variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). It causes a frameshift starting with codon Isoleucine 3210, changes this amino acid to an Arginine residue and creates a premature Stop codon at position 5 of the new reading frame, denoted p.Ile3210ArgfsX5. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. We interpret this variant as pathogenic.
Baylor Genetics RCV003473287 SCV004210636 pathogenic Pituitary adenoma 5, multiple types 2023-08-14 criteria provided, single submitter clinical testing
Invitae RCV001009201 SCV004613625 pathogenic not provided 2024-01-22 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ile3210Argfs*5) in the CDH23 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDH23 are known to be pathogenic (PMID: 11138009, 21940737). This variant is present in population databases (rs397517367, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 33111992). ClinVar contains an entry for this variant (Variation ID: 46077). For these reasons, this variant has been classified as Pathogenic.
Natera, Inc. RCV001831682 SCV002086309 pathogenic Usher syndrome type 1 2021-02-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.